All
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
Top results
EyeCon 2024: Program co-chair Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
8 months ago
ophthalmologytimes.com
ASCRS 2024: George O. Waring IV, MD, shares early results of bilateral implantation with novel IOL technology
9 months ago
ophthalmologytimes.com
Real World Ophthalmology: A day packed with insights, innovation, and awards
Sep 20, 2023
ophthalmologytimes.com
Visus Therapeutics CEO announces acquisition of ViewPoint Therapeutics to expand on cataract, presbyopia candidate
Sep 30, 2022
ophthalmologytimes.com
Absolute Contraindications to Intravitreal Injection and Managing Patients With Contraindications
Jul 27, 2022
ophthalmologytimes.com
Phase 3 LUGANO Trial explores EYP-1901’s potential to reduce treatment burden in wet AMD Patients
2 months ago
ophthalmologytimes.com
2:20
ASCRS 2024: What advancements in Light Adjustable Lens technology mean for clinicians and patients
9 months ago
ophthalmologytimes.com
Retina Society 2024: Advances in AMD therapy highlight different mechanisms of action with a common goal
4 months ago
ophthalmologytimes.com
(VLOG) NeuroOp Guru: Can a dead nerve swell?
1 week ago
ophthalmologytimes.com
Carl Zeiss Meditec to acquire Acri.Tec AG
Sep 4, 2007
ophthalmologytimes.com
AAO 2023: Neurotech's encapsulated cell therapy, NT-501
Nov 9, 2023
ophthalmologytimes.com
AAO 2024: Energy drinks and central retinal vein occlusions
3 months ago
ophthalmologytimes.com
Snowmass Retina and Eye 2025: Ronald Frenkel, MD, previews interactive learning and innovation amid winter fun
1 week ago
ophthalmologytimes.com
ASRS 2024: Results from part 1 of the Phase 2/3 SIGLEC trial assessing AVD-104 for GA
6 months ago
ophthalmologytimes.com
Promising non-surgical treatment for early cataracts: Insights from a Phase II clinical trial
2 months ago
ophthalmologytimes.com
Mixing and Matching Monofocal Plus IOLs with Other Advanced Technology IOLs
6 months ago
ophthalmologytimes.com
Patient Case #1: 58-year-old patient with open angle glaucoma utilizing minimally invasive glaucoma surgery procedure
Jun 30, 2022
ophthalmologytimes.com
Anthony Wallace of Bausch Lomb talks about enVista Envy FDA approval
3 months ago
ophthalmologytimes.com
Key Considerations for Selecting a Premium Intraocular Lens
Oct 10, 2023
ophthalmologytimes.com
ASRS 2024: Neurotech Pharmaceuticals update on the NT-501 device
6 months ago
ophthalmologytimes.com
Trukera Medical rebranding allows team to expand into the broader corneal health market
Oct 11, 2022
ophthalmologytimes.com
Patient case 1: Neovascular AMD Patient Treated with Ranibizumab Biosimilar
11 months ago
ophthalmologytimes.com
ARVO 2024: A study on multi-ingredient oral supplement for dry eye symptoms and tear volume
8 months ago
ophthalmologytimes.com
Retina Society 2024: Population pharmacokinetic modeling and simulation of ocular clearance of aflibercept 8 mg and 2 mg
4 months ago
ophthalmologytimes.com
Chris Brittain of Genentech discusses FDA approval to relaunch Susvimo
6 months ago
ophthalmologytimes.com
Perspectives on Latest Therapies: Faricimab and Aflibercept 8mg
4 months ago
ophthalmologytimes.com
MOA of Faricimab and 2-Year Data Review
Aug 30, 2022
ophthalmologytimes.com
AAO 2023: OTT166 progress: OcuTerra's diabetic retinopathy treatment
Nov 3, 2023
ophthalmologytimes.com
AGS 2024: Glaucoma management is all about the patient
11 months ago
ophthalmologytimes.com
Overview of Biosimilars for Treating Retinal Diseases
Nov 28, 2023
ophthalmologytimes.com
See more videos
Feedback
Feedback